Table 1 The characteristics of patients for qRT-PCR and IHC.

From: High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition

Clinicopathologic features

IHC

qRT-PCR

Number (%)

Number (%)

All patients

109

27

Age, year

>60

47 (43.1%)

18 (66.7%)

≤60

62 (56.9%)

9 (33.3%)

Gender

Male

54 (49.5%)

11 (40.7%)

Female

55 (50.5%)

16 (59.3%)

Differential degree

High

23 (21.1%)

2 (7.4%)

Moderate

61 (56.0%)

13 (48.1%)

Low

25 (22.9%)

12 (44.4%)

T stage

T1-2

93(85.32%)

21 (77.8%)

T3-4

16 (14.7%)

6 (22.2%)

N status

N−

58 (53.2%)

12 (44.4%)

N+

51 (46.8%)

15 (55.6%)

Pathological stage

I

47 (43.1%)

5 (18.5%)

II

22 (20.2%)

9 (33.3%)

III

40 (36.7%)

13 (48.1%)